Plasmaaustausch

Plasmaaustausch, also known as plasmapheresis, is a medical procedure that separates plasma from blood and then returns the remaining blood components to the donor. This process involves drawing blood from the patient, passing it through a special machine that filters out the plasma, and then reinfusing the blood cells and remaining plasma back into the patient.

The primary purpose of plasma exchange is to remove harmful substances from the blood, such as antibodies, toxins, or abnormal proteins. These substances can contribute to various diseases and conditions. By removing the plasma containing these harmful elements, the procedure aims to alleviate symptoms and slow disease progression.

Plasma exchange is used to treat a range of autoimmune diseases, neurological disorders, and certain kidney conditions. Examples include myasthenia gravis, Guillain-Barré syndrome, lupus nephritis, and thrombotic thrombocytopenic purpura. The decision to perform plasma exchange is made by a medical professional based on the specific patient's condition and the potential benefits of the treatment.

The procedure typically takes place in a hospital or specialized clinic setting. It is generally considered safe, but like any medical intervention, it carries potential risks and side effects. These can include temporary drops in blood pressure, citrate toxicity (due to the anticoagulant used), or infection at the access site. Medical professionals closely monitor patients during and after the procedure to manage any adverse reactions.